U.S. Markets closed

ChemoCentryx: 2Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Monday reported a loss of $15.2 million in its second quarter.

On a per-share basis, the Mountain View, California-based company said it had a loss of 26 cents.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.

The biopharmaceutical company posted revenue of $7.2 million in the period, also missing Street forecasts. Six analysts surveyed by Zacks expected $10.1 million.

ChemoCentryx shares have decreased 30% since the beginning of the year. In the final minutes of trading on Monday, shares hit $7.62, a fall of 31% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CCXI at https://www.zacks.com/ap/CCXI